Be Careful With FDA’s New Compliant-Manufacturing Resumption Guidance

Jack Garvey, founder and CEO of Compliance Architects, a firm specializing in GMP, quality and compliance services, calls for caution in applying the FDA’s new compliant-manufacturing resumption guidance.
Source: Drug GMP Report